141 related articles for article (PubMed ID: 31280618)
1. Primary prostate lymphoma: A case report and literature review.
Wang K; Wang N; Sun J; Fan Y; Chen L
Int J Immunopathol Pharmacol; 2019; 33():2058738419863217. PubMed ID: 31280618
[TBL] [Abstract][Full Text] [Related]
2. [Malignant lymphoma of the prostate--diagnosis on the second biopsy].
Vetsch G; Baumann CK; Kläy M; Leupin N; Rentsch C; Mueller-Garamvölgyi E; Bürgi U; Schiemann U
Med Klin (Munich); 2008 Apr; 103(4):245-8. PubMed ID: 18484209
[TBL] [Abstract][Full Text] [Related]
3. A Case of Primary Malignant Lymphoma of the Prostate Gland Presenting as Right Lower Back Pain and Dysuria.
Yasuoka S; Kimura G; Toyama Y; Moriya K; Takahashi K; Matsuoka R; Shibayama K; Obayashi K; Inoue Y; Shindo T; Iigaya S; Endo Y; Akatsuka J; Hayashi T; Nakayama S; Hamasaki T; Inokuchi K; Kondo Y
J Nippon Med Sch; 2018; 85(4):236-240. PubMed ID: 30259894
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma of the prostate.
Warrick JI; Owens SR; Tomlins SA
Arch Pathol Lab Med; 2014 Oct; 138(10):1286-9. PubMed ID: 25268190
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range.
Kefi A; Irer B; Ozdemir I; Tuna B; Goktay Y; Yorukoğlu K; Esen A
Urol Int; 2005; 75(3):222-6. PubMed ID: 16215309
[TBL] [Abstract][Full Text] [Related]
7. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
Bissoli E; Fandella A; La Torre E; Faggiano L; Anselmo G; Frasson F
Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.
Crook J; Robertson S; Collin G; Zaleski V; Esche B
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):31-7. PubMed ID: 7690016
[TBL] [Abstract][Full Text] [Related]
9. [A case of primary malignant lymphoma of the prostate with characteristic MRI findings].
Hori Y; Nishii M; Masui S; Yoshio Y; Hasegawa Y; Kanda H; Yamada Y; Arima K; Sugimura Y
Hinyokika Kiyo; 2013 Jun; 59(6):377-80. PubMed ID: 23827872
[TBL] [Abstract][Full Text] [Related]
10. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
11. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
[TBL] [Abstract][Full Text] [Related]
12. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
13. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Abdom Imaging; 1996; 21(4):364-7. PubMed ID: 8661585
[TBL] [Abstract][Full Text] [Related]
14. [Malignant lymphoma of the prostate--a case report].
Suwa Y; Noguchi S; Sakuramoto T; Shuin T; Kinoshita Y; Kubota Y; Hosaka M
Hinyokika Kiyo; 1993 Dec; 39(12):1171-4. PubMed ID: 8285167
[TBL] [Abstract][Full Text] [Related]
15. Primary lymphoma of prostate presenting as bladder outflow obstruction.
Fell P; O'Connor M; Smith JM
Urology; 1987 May; 29(5):555-6. PubMed ID: 3554699
[TBL] [Abstract][Full Text] [Related]
16. Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer.
Huellner MW; Mattei A; Ross S; Butea-Bocu M; Vosbeck J; Pauli C; Diebold J; Seifert B; Strobel K; Veit-Haibach P
Clin Imaging; 2014; 38(6):850-7. PubMed ID: 25168905
[TBL] [Abstract][Full Text] [Related]
17. Prostate involvement by intravascular large B-cell lymphoma: a case report with literature review.
Xu M; Yang Q; Li M; Geng W; Huang W; Chen Y
Int J Surg Pathol; 2011 Aug; 19(4):544-7. PubMed ID: 21632638
[TBL] [Abstract][Full Text] [Related]
18. Intravascular large B cell lymphoma of prostate, a rare entity.
Rallabandi HB; Thirukovela J; Swain M; Meeramira D; Gowrishankar S
Indian J Pathol Microbiol; 2021; 64(3):575-578. PubMed ID: 34341277
[TBL] [Abstract][Full Text] [Related]
19. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
20. A case of prostate cancer in 34 year old man presenting with generalized lymphadenopathy mimicking malignant lymphoma.
Ahn MJ; Oh SJ; Lee YY; Jung TJ; Kim IS; Choi IY; Jang SJ; Park YW; Shin KY; Kim YS
J Korean Med Sci; 1997 Jun; 12(3):262-5. PubMed ID: 9250926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
